DAXOR CORP
DXRNASDAQ🏆 #4248 by market capUS Equity
$9.26▼ $0.82 (−8.13%)
Latest quoteTrack DXR
Get earnings, price moves & breaking news on Telegram
24h▼ 8.1%
7d▼ 8.1%
14d▼ 8.1%
30d▼ 17.0%
ytd▼ 21.4%
1y▼ 33.2%
🏦Market Cap
$54M
Small Cap
📈Revenue Growth (YoY)
-52.7%
Declining
📊Gross Margin
-5771.1%
Thin
💵FCF Margin
1820.6%
Strong
⚖️P/S Ratio
1697.6x
Expensive
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $9.26 – $9.26
- 52-Week Range
- $8.56 – $14.76
- Volume (shares)
- 100
- Avg Volume (shares)
- —
- Shares Outstanding
- 5.8M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- $503,424
- Last Q Revenue
- $23,020
- P/E Ratio
- 8.5
- P/S Ratio
- 1697.6x
- EPS (TTM)
- $1.52
- Dividend Yield
- —
- Dilution (1yr)
- +2.5%
DAXOR CORP
DXRFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$503K▼ −76.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
37.5%▼ −62.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$9M▲ +1378.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$604K▼ −2452.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
5.1M▲ +2.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$112K▲ +$618K YoY
StockOtter · stockotter.spaceAbout DAXOR CORP
Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is utilized across a wide spectrum of medical and surgical contexts. Prior to May 1973, the organization operated under the name Idant Corporation.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst Ratings
ⓘConsensus
Buy
6 analysts
Strong Buy1
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026
Latest News & Updates
News unavailable.